← All stocks

Elanco Animal Health Inc

ELAN Net selling
CIK 0001739104 #870 in the set updated 17 Sep 2026
Bought (120 mo)
$17.35M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.63B
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.63B
1 of 1 sales
Net
−$1.61B
−$1.61B against sales at will

By person

37 insiders · 86 transactions
43.3×

Jeffrey Simmons holds 43.3 times base salary in stock. $52.03M of shares against $1.20M in salary for 2025.

Salary from the company's own proxy. The shares are what Jeffrey Simmons last reported holding, valued at $23.40, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BAYER AKTIENGESELLSCHAFT
10% owner
$1.63B (1)
−$1.63B
18,446,429
3.69%
$431.61M
−74.7%
HOOVER R DAVID
Director
$5.51M (24)
+$5.51M
261,451
0.0523%
$6.12M
Simmons Jeffrey N
PRESIDENT, CEO AND DIRECTOR
$5.50M (9)
+$5.50M
2,223,869
0.4451%
$52.03M
+158,975%
Kurzius Lawrence Erik
Director
$1.60M (5)
+$1.60M
188,647
0.0378%
$4.41M
BILBREY JOHN P
Director
$997.12K (6)
+$997.12K
120,122
0.0240%
$2.81M
+95,235%
Harrington Michael J
Director
$560.61K (7)
+$560.61K
131,451
0.0263%
$3.08M
DOYLE WILLIAM F
Director
$499.20K (2)
+$499.20K
94,499
0.0189%
$2.21M
LIN SARENA S
See Remarks
$480.00K (1)
+$480.00K
66,051
0.0132%
$1.55M
YOUNG TODD S.
SEE REMARKS
$433.10K (3)
+$433.10K
142,366
0.0285%
$3.33M
Hicks Michael-Bryant
See Remarks
$413.91K (2)
+$413.91K
55,588
0.0111%
$1.30M
Herendeen Paul
Director
$387.10K (2)
+$387.10K
111,687
0.0224%
$2.61M
Modi Rajeev A.
SEE REMARKS
$295.75K (3)
+$295.75K
160,812
0.0322%
$3.76M
+1,859%
VanHimbergen Robert M
EVP and CFO
$247.35K (2)
+$247.35K
137,516
0.0275%
$3.22M
+1,583%
GARCIA ART A
Director
$99.66K (2)
+$99.66K
108,152
0.0216%
$2.53M
O'Neill Shiv
GC AND CORP SEC
$94.27K (1)
+$94.27K
87,832
0.0176%
$2.06M
+899.3%
Anand Kapila K
Director
$84.14K (3)
+$84.14K
111,847
0.0224%
$2.62M
Kinard David S
SEE REMARKS
$60.00K (2)
+$60.00K
214,264
0.0429%
$5.01M
+3,520%
Kochevar Deborah Turner
Director
$27.95K (1)
+$27.95K
94,392
0.0189%
$2.21M
Cabral Ramiro Martin
SEE REMARKS
$24.00K (2)
+$24.00K
283,874
0.0568%
$6.64M
Urbanek David Alan
SEE REMARKS
$17.99K (5)
+$17.99K
114,459
0.0229%
$2.68M
Schacht Aaron L
Executive Vice President
$9.60K (2)
+$9.60K
78,747
0.0158%
$1.84M
Meer James M
CHIEF ACCOUNTING OFFICER
$5.40K (1)
+$5.40K
66,732
0.0134%
$1.56M
de Brabander Ellen
SEE REMARKS
280,821
0.0562%
$6.57M
Bettington Timothy J
SEE REMARKS
143,261
0.0287%
$3.35M
Scots-Knight Denise
Director
105,588
0.0211%
$2.47M
McDonald Kirk P
Director
105,588
0.0211%
$2.47M
McArdle Grace
EVP, MANUFACTURING AND QUALITY
103,705
0.0208%
$2.43M
+363.4%
Correia de Simas Jose Manuel
SEE REMARKS
101,017
0.0202%
$2.36M
Kirberger Marcela A.
SEE REMARKS
47,016
0.0094%
$1.10M
Lee Joyce J.
Ex VP Prs US Pet Hlth Com Op
34,628
0.0069%
$810.23K
Ma Stacey
Director
29,727
0.0059%
$695.55K
Mason Racquel Harris
See Remarks
23,770
0.0048%
$556.17K
Turner Kathy V
Director
13,838
0.0028%
$323.78K
Wallace Craig S.
Director
13,838
0.0028%
$323.78K
Ehle Dirk
Ex VP & Pres Elanco Europe
11,241
0.0022%
$263.02K
Ferguson Scott D.
Director
7,307
0.0015%
$170.97K
LILLY ELI & CO entity
10% owner
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
BAYER AKTIENGESELLSCHAFT
3 Dec 2020
10% owner
Sell indirect
54,500,000
$29.84
$1.63B

What was left out

Form 4 filings counted 651
Amendments (4/A) skipped 0
Filings about a different issuer 1
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 6
Shares from compensation/vesting 303,328,801
Sales filed before the plan box existed 1
History held since 26 Sep 2018